SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* OConnell Christopher J (Last) (First) (Middle) C/O MEDTRONIC INC, 710 MEDTRONIC PKWY MS LC300 (Street) MINNEAPOLIS MN 55432 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Medtronic plc [ MDT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) See Remarks
	3. Date of Earliest Transaction (Month/Day/Year) 01/26/2015
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	01/26/2015		A		98,706	A	(1)	98,706	D
Ordinary Shares	01/26/2015		A		2,654	A	(1)	2,654	I	by ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$48.7	01/26/2015		A		15,401		(2)	10/30/2016	Ordinary Shares	15,401	(2)	15,401	D
Employee Stock Option (right to buy)	$47.77	01/26/2015		A		17,794		(3)	10/29/2017	Ordinary Shares	17,794	(3)	17,794	D
Employee Stock Option (right to buy)	$36.24	01/26/2015		A		33,113		(4)	10/27/2018	Ordinary Shares	33,113	(4)	33,113	D
Employee Stock Option (right to buy)	$35.92	01/26/2015		A		33,408		(5)	08/03/2019	Ordinary Shares	33,408	(5)	33,408	D
Employee Stock Option (right to buy)	$36.12	01/26/2015		A		27,686		(6)	11/02/2019	Ordinary Shares	27,686	(6)	27,686	D
Employee Stock Option (right to buy)	$37.53	01/26/2015		A		70,984		(7)	08/02/2020	Ordinary Shares	70,984	(7)	70,984	D
Employee Stock Option (right to buy)	$34.88	01/26/2015		A		84,060		(8)	08/01/2021	Ordinary Shares	84,060	(8)	84,060	D
Employee Stock Option (right to buy)	$38.81	01/26/2015		A		75,548		(9)	07/30/2022	Ordinary Shares	75,548	(9)	75,548	D
Employee Stock Option (right to buy)	$41.6	01/26/2015		A		2,404		(10)	10/29/2022	Ordinary Shares	2,404	(10)	2,404	D
Employee Stock Option (right to buy)	$55.32	01/26/2015		A		60,250		(11)	07/29/2023	Ordinary Shares	60,250	(11)	60,250	D
Employee Stock Option (right to buy)	$55.32	01/26/2015		A		1,808		(12)	07/29/2023	Ordinary Shares	1,808	(12)	1,808	D
Employee Stock Option (right to buy)	$62.76	01/26/2015		A		1,594		(13)	07/28/2024	Ordinary Shares	1,594	(13)	1,594	D
Employee Stock Option (right to buy)	$62.76	01/26/2015		A		56,852		(14)	07/28/2024	Ordinary Shares	56,852	(14)	56,852	D

Explanation of Responses:

1. Represents shares of Medtronic plc ("New Medtronic") acquired pursuant to the merger (the "Merger") of a wholly-owned subsidiary of New Medtronic with and into Medtronic, Inc. ("Medtronic"), with Medtronic surviving as a wholly-owned subsidiary of New Medtronic, which was consummated after and conditioned on New Medtronic's acquisition of Covidien plc, by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. At the effective time of the Merger, each Medtronic common share was cancelled and converted into the right to receive one New Medtronic ordinary share. Under the terms of the Merger, the officer received cash in lieu of fractional shares of New Medtronic and restricted stock units were rounded up to the nearest whole share.

2. This option to purchase 15,401 ordinary shares of New Medtronic for $48.70 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 15,401 Medtronic common stock shares for $48.70 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

3. This option to purchase 17,794 New Medtronic ordinary shares for $47.77 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 17,794 Medtronic common stock shares for $47.77 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

4. This option to purchase 33,113 New Medtronic ordinary shares for $36.24 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 33,113 Medtronic common stock shares for $36.24 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

5. This option to purchase 33,408 New Medtronic ordinary shares for $35.92 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 33,408 Medtronic common stock shares for $35.92 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

6. This option to purchase 27,686 New Medtronic ordinary shares for $36.12 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 27,686 Medtronic common stock shares for $36.12 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

7. This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

8. This option to purchase 84,060 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 84,060 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

9. This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

10. This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

11. This option to purchase 60,250 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 60,250 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

12. This option to purchase 1,808 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,808 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

13. This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

14. This option to purchase 56,852 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 56,852 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney

	/s/ Rhonda L. Ingalsbe, Attorney-in-fact	01/28/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.